These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8892778)

  • 1. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography.
    Posma JL; Blanksma PK; van der Wall EE; Hamer HP; Mooyaart EL; Lie KI
    Am Heart J; 1996 Nov; 132(5):1020-7. PubMed ID: 8892778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy.
    Gaudio C; Pelliccia F; Tanzilli G; Mazzarotto P; Cianfrocca C; Marino B
    Clin Cardiol; 1992 Mar; 15(3):164-8. PubMed ID: 1551263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging.
    Pons-Lladó G; Carreras F; Borrás X; Palmer J; Llauger J; Bayés de Luna A
    Am J Cardiol; 1997 Jun; 79(12):1651-6. PubMed ID: 9202357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging.
    Romano R; Losi MA; Migliore T; Contaldi C; Parrella LS; Caputi A; Betocchi S
    Minerva Cardioangiol; 2008 Apr; 56(2):181-7. PubMed ID: 18319696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI in hypertrophic cardiomyopathy: a morphofunctional study.
    Sardanelli F; Molinari G; Petillo A; Ottonello C; Parodi RC; Masperone MA; Saitta S; Basso M; Caponnetto S
    J Comput Assist Tomogr; 1993; 17(6):862-72. PubMed ID: 8227570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of hypertrophic cardiomyopathy with magnetic resonance].
    Di Cesare E; Marsili L; Chichiarelli A; Di Renzi P; Costanzi A; Lupattelli L
    Radiol Med; 1994 May; 87(5):614-9. PubMed ID: 8008891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy.
    Guarise A; Faccioli N; Foti G; Da Pozzo S; Meneghetti P; Morana G
    Radiol Med; 2011 Mar; 116(2):197-210. PubMed ID: 20981502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
    Amano Y; Takayama M; Takahama K; Kumazaki T
    J Magn Reson Imaging; 2004 Oct; 20(4):595-600. PubMed ID: 15390225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of magnetic resonance and echocardiographic correlations in the evaluation of hypertrophic cardiomyopathy].
    Fattori R; Rapezzi C; Castriota F; Magnani G; Bertaccini P; Galiè N; Magnani B; Gavelli G
    Radiol Med; 1994; 88(1-2):36-43. PubMed ID: 8066253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and hypertrophic segments distribution of patients with hypertrophic cardiomyopathy].
    YAN CW; ZHAO SH; LI H; JIANG SL; LU MJ; ZHANG Y; WEI YQ; LING J; FANG W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):781-5. PubMed ID: 21092643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
    Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular mass in hypertrophic cardiomyopathy: assessment by three-dimensional and geometric MR methods.
    Soler R; Rodríguez E; Marini M
    J Comput Assist Tomogr; 1999; 23(4):577-82. PubMed ID: 10433290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.